113 related articles for article (PubMed ID: 30219588)
1. Docking and pharmacodynamic studies on hGAT1 inhibition activity in the presence of selected neuronal and astrocytic inhibitors. Part I.
Nowaczyk A; Fijałkowski Ł; Zaręba P; Sałat K
J Mol Graph Model; 2018 Oct; 85():171-181. PubMed ID: 30219588
[TBL] [Abstract][Full Text] [Related]
2. Potential role of selected antiepileptics used in neuropathic pain as human GABA transporter isoform 1 (GAT1) inhibitors-Molecular docking and pharmacodynamic studies.
Fijałkowski Ł; Sałat K; Podkowa A; Zaręba P; Nowaczyk A
Eur J Pharm Sci; 2017 Jan; 96():362-372. PubMed ID: 27721044
[TBL] [Abstract][Full Text] [Related]
3. Studies on the Activity of Selected Highly Lipophilic Compounds toward hGAT1 Inhibition. Part II.
Nowaczyk A; Fijałkowski Ł; Kowalska M; Podkowa A; Sałat K
ACS Chem Neurosci; 2019 Jan; 10(1):337-347. PubMed ID: 30222312
[TBL] [Abstract][Full Text] [Related]
4. Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice.
Zaręba P; Gryzło B; Malawska K; Sałat K; Höfner GC; Nowaczyk A; Fijałkowski Ł; Rapacz A; Podkowa A; Furgała A; Żmudzki P; Wanner KT; Malawska B; Kulig K
Eur J Med Chem; 2020 Feb; 188():111920. PubMed ID: 31901745
[TBL] [Abstract][Full Text] [Related]
5. Development of Highly Potent GAT1 Inhibitors: Synthesis of Nipecotic Acid Derivatives with N-Arylalkynyl Substituents.
Lutz T; Wein T; Höfner G; Wanner KT
ChemMedChem; 2017 Mar; 12(5):362-371. PubMed ID: 28125164
[TBL] [Abstract][Full Text] [Related]
6. Structure activity relationship of selective GABA uptake inhibitors.
Vogensen SB; Jørgensen L; Madsen KK; Jurik A; Borkar N; Rosatelli E; Nielsen B; Ecker GF; Schousboe A; Clausen RP
Bioorg Med Chem; 2015 May; 23(10):2480-8. PubMed ID: 25882526
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, Evaluation and Computational Studies of Nipecotic Acid-Acetonaphthone Hybrids as Potential Antiepileptic Agents.
Seth A; Sharma PA; Tripathi A; Choubey PK; Srivastava P; Tripathi PN; Shrivastava SK
Med Chem; 2018; 14(4):409-426. PubMed ID: 29336266
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological properties of new GABA uptake inhibitors.
Sałat K; Więckowska A; Więckowski K; Höfner GC; Kamiński J; Wanner KT; Malawska B; Filipek B; Kulig K
Pharmacol Rep; 2012; 64(4):817-33. PubMed ID: 23087134
[TBL] [Abstract][Full Text] [Related]
9. Stereospecific synthesis and structure-activity relationships of unsymmetrical 4,4-diphenylbut-3-enyl derivatives of nipecotic acid as GAT-1 inhibitors.
Pizzi DA; Leslie CP; Di Fabio R; Seri C; Bernasconi G; Squaglia M; Carnevale G; Falchi A; Greco E; Mangiarini L; Negri M
Bioorg Med Chem Lett; 2011 Jan; 21(1):602-5. PubMed ID: 21134748
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors.
Quandt G; Höfner G; Wanner KT
Bioorg Med Chem; 2013 Jun; 21(11):3363-78. PubMed ID: 23598250
[TBL] [Abstract][Full Text] [Related]
11. MS-Based Screening of 5-Substituted Nipecotic Acid Derived Hydrazone Libraries as Ligands of the GABA Transporter 1.
Hauke TJ; Höfner G; Wanner KT
ChemMedChem; 2019 Mar; 14(5):583-593. PubMed ID: 30663849
[TBL] [Abstract][Full Text] [Related]
12. GRID-independent molecular descriptor analysis and molecular docking studies to mimic the binding hypothesis of γ-aminobutyric acid transporter 1 (GAT1) inhibitors.
Zafar S; Jabeen I
PeerJ; 2019; 7():e6283. PubMed ID: 30723616
[TBL] [Abstract][Full Text] [Related]
13. Molecular Dynamic Simulations to Probe Stereoselectivity of Tiagabine Binding with Human GAT1.
Zafar S; Jabeen I
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081136
[TBL] [Abstract][Full Text] [Related]
14. Identification of the First Highly Subtype-Selective Inhibitor of Human GABA Transporter GAT3.
Damgaard M; Al-Khawaja A; Vogensen SB; Jurik A; Sijm M; Lie ME; Bæk MI; Rosenthal E; Jensen AA; Ecker GF; Frølund B; Wellendorph P; Clausen RP
ACS Chem Neurosci; 2015 Sep; 6(9):1591-9. PubMed ID: 26154082
[TBL] [Abstract][Full Text] [Related]
15. Astrocytic GABA Transporters: Pharmacological Properties and Targets for Antiepileptic Drugs.
Schousboe A; Wellendorph P; Frølund B; Clausen RP; Krogsgaard-Larsen P
Adv Neurobiol; 2017; 16():283-296. PubMed ID: 28828616
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with an alkyne spacer as GABA uptake inhibitors.
Tóth K; Höfner G; Wanner KT
Bioorg Med Chem; 2018 Jul; 26(12):3668-3687. PubMed ID: 29886082
[TBL] [Abstract][Full Text] [Related]
17. 2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
Kowalczyk P; Sałat K; Höfner GC; Guzior N; Filipek B; Wanner KT; Kulig K
Bioorg Med Chem; 2013 Sep; 21(17):5154-67. PubMed ID: 23859778
[TBL] [Abstract][Full Text] [Related]
18. Generation and screening of pseudostatic hydrazone libraries derived from 5-substituted nipecotic acid derivatives at the GABA transporter mGAT4.
Hauke TJ; Höfner G; Wanner KT
Bioorg Med Chem; 2019 Jan; 27(1):144-152. PubMed ID: 30503411
[TBL] [Abstract][Full Text] [Related]
19. Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors.
Hack S; Wörlein B; Höfner G; Pabel J; Wanner KT
Eur J Med Chem; 2011 May; 46(5):1483-98. PubMed ID: 21353350
[TBL] [Abstract][Full Text] [Related]
20. Development of tricyclic N-benzyl-4-hydroxybutanamide derivatives as inhibitors of GABA transporters mGAT1-4 with anticonvulsant, antinociceptive, and antidepressant activity.
Zaręba P; Sałat K; Höfner GC; Łątka K; Bajda M; Latacz G; Kotniewicz K; Rapacz A; Podkowa A; Maj M; Jóźwiak K; Filipek B; Wanner KT; Malawska B; Kulig K
Eur J Med Chem; 2021 Oct; 221():113512. PubMed ID: 34015586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
